These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35315528)

  • 1. Identifying nonhazardous substances in pharmaceutical manufacturing and setting default health-based exposure limits (HBELs).
    Wiesner L; Araya S; Lovsin Barle E
    J Appl Toxicol; 2022 Sep; 42(9):1443-1457. PubMed ID: 35315528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approaches for setting occupational exposure limits in the pharmaceutical industry.
    Ahuja V; Krishnappa M
    J Appl Toxicol; 2022 Jan; 42(1):154-167. PubMed ID: 34254327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of permitted daily exposure (PDE) values for active pharmaceutical ingredients (APIs) - Evidence of a robust approach.
    Sehner C; Bernier T; Blum K; Clemann N; Glogovac M; Hawkins WA; Kohan M; Linker F; Lovsin-Barle E; Osadolor O; Pfister T; Schulze E; Schwind M; Tuschl G; Wiesner L
    Regul Toxicol Pharmacol; 2024 Jun; 150():105649. PubMed ID: 38782234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deriving harmonised permitted daily exposures (PDEs) for paracetamol (acetaminophen) CAS #: 103-90-2.
    Gromek K; Hawkins W; Bernier T; Sehner C; Zeller E; Schwind M; Pfister T; Kohan M; Osadolor O; Glogovac M; Tuschl G; Dolan DG; Lovsin Barle E
    Regul Toxicol Pharmacol; 2020 Aug; 115():104692. PubMed ID: 32522580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Setting impurity limits for endogenous substances: Recommendations for a harmonized procedure and an example using fatty acids.
    Jolly RA; Bandara S; Bercu J; Callis CM; Dolan DG; Graham J; HaMai D; Barle EL; Maier A; Masuda-Herrera M; Moudgal C; Parker JA; Reichard J; Sandhu R; Fung ES
    Regul Toxicol Pharmacol; 2022 Oct; 134():105242. PubMed ID: 35964842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A harmonization effort for acceptable daily exposure application to pharmaceutical manufacturing - Operational considerations.
    Hayes EP; Jolly RA; Faria EC; Barle EL; Bercu JP; Molnar LR; Naumann BD; Olson MJ; Pecquet AM; Sandhu R; Shipp BK; Sussman RG; Weideman PA
    Regul Toxicol Pharmacol; 2016 Aug; 79 Suppl 1():S39-47. PubMed ID: 27267172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Setting occupational exposure limits for antimicrobial agents: A case study based on a quaternary ammonium compound-based disinfectant.
    Dotson GS; Lotter JT; Zisook RE; Gaffney SH; Maier A; Colvin J
    Toxicol Ind Health; 2020 Sep; 36(9):619-633. PubMed ID: 33241765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease area and mode of action as criteria to assign a default occupational exposure limit.
    Glogovac M; Paulson C; Lambert A; Winkler GC; Lovsin Barle E
    Regul Toxicol Pharmacol; 2021 Jun; 122():104891. PubMed ID: 33587935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A scoping survey of attitudes towards occupational exposure limits and REACH derived no effect levels for workers among chemical risk managers at Swedish workplaces.
    Schenk L
    Int J Occup Med Environ Health; 2020 Sep; 33(5):611-620. PubMed ID: 32699425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Setting Occupational Exposure Limits for Genotoxic Substances in the Pharmaceutical Industry.
    Lovsin Barle E; Winkler GC; Glowienke S; Elhajouji A; Nunic J; Martus HJ
    Toxicol Sci; 2016 May; 151(1):2-9. PubMed ID: 27207978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigations of the use of bioavailability data to adjust occupational exposure limits for active pharmaceutical ingredients.
    Naumann BD; Weideman PA; Sarangapani R; Hu SC; Dixit R; Sargent EV
    Toxicol Sci; 2009 Nov; 112(1):196-210. PubMed ID: 19692668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applicability of surface sampling and calculation of surface limits for pharmaceutical drug substances for occupational health purposes.
    Jandard C; Hemming H; Prause M; Sehner C; Schwind M; Abromovitz M; Lovsin Barle E
    Regul Toxicol Pharmacol; 2018 Jun; 95():434-441. PubMed ID: 29288720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Misinterpretation and misuse of exposure limits.
    Hewett P
    Appl Occup Environ Hyg; 2001 Feb; 16(2):251-6. PubMed ID: 11217719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative study on occupational exposure limits of chemical substances in workplace between GBZ 2.1 in China and ACGIH in USA].
    Li W; Zhang M; Wang D
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2014 Jan; 32(1):1-26. PubMed ID: 24428986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using default methodologies to derive an acceptable daily exposure (ADE).
    Faria EC; Bercu JP; Dolan DG; Morinello EJ; Pecquet AM; Seaman C; Sehner C; Weideman PA
    Regul Toxicol Pharmacol; 2016 Aug; 79 Suppl 1():S28-38. PubMed ID: 27233926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of REACH-derived no-effect levels for workers with EU indicative occupational exposure limit values and national limit values in Finland.
    Tynkkynen S; Santonen T; Stockmann-Juvala H
    Ann Occup Hyg; 2015 May; 59(4):401-15. PubMed ID: 25638729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges in setting permitted daily exposure limits for pharmaceuticals: A review.
    Ahuja V; Krishnappa M
    Int J Risk Saf Med; 2022; 33(1):49-64. PubMed ID: 34924402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical otic drugs in a multi-purpose manufacturing facility: a guide on determination and application of permitted daily exposure (PDE).
    Wiesner L; Prause M; Lovsin Barle E
    Pharm Dev Technol; 2018 Mar; 23(3):261-264. PubMed ID: 28535123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Derivation of occupational exposure limits: Differences in methods and protection levels.
    Schneider K; Dilger M; Drossard C; Ott H; Kaiser E
    J Appl Toxicol; 2022 May; 42(5):913-926. PubMed ID: 35188277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Global Landscape of Occupational Exposure Limits--Implementation of Harmonization Principles to Guide Limit Selection.
    Deveau M; Chen CP; Johanson G; Krewski D; Maier A; Niven KJ; Ripple S; Schulte PA; Silk J; Urbanus JH; Zalk DM; Niemeier RW
    J Occup Environ Hyg; 2015; 12 Suppl 1(sup1):S127-44. PubMed ID: 26099071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.